Bloomberg Intelligence cover image

Novo Next-Generation Obesity Shot Falls Short of Lilly Rival

Bloomberg Intelligence

00:00

Novo's next-gen shot underperforms Lilly

Sam Fazeli explains Kagri Sema's trial loss versus Eli Lilly and what the direct head-to-head failure means for Novo Nordisk.

Play episode from 01:32
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app